US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist

3.710
-0.040-1.07%

Close Aug 16 16:00 ET

3.720
+0.010+0.27%

Post 20:02 ET

700.38MMarket Cap-8244P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

25.84%-14.5M

29.32%-19.3M

-143.06%-85.94M

-1.78%-17.29M

-16.54%-21.78M

3.62%-19.56M

-232.41%-27.3M

47.65%-35.36M

13.34%-16.99M

-16.56%-18.69M

Net income from continuing operations

-15.81%-19.8M

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

8.91%-69.46M

-2.87%-21.93M

8.30%-17.57M

Operating gains losses

----

---20K

--0

----

--0

Depreciation and amortization

4.09%356K

6.29%355K

-1.61%1.4M

16.94%359K

7.58%369K

-10.70%342K

-15.23%334K

-18.60%1.43M

-28.10%307K

-23.27%343K

Other non cash items

73.56%-326K

46.75%-377K

9.60%-3.34M

-171.93%-930K

72.27%-472K

-23.55%-1.23M

-7.93%-708K

-166.81%-3.7M

75.47%-342K

-600.41%-1.7M

Change In working capital

168.88%2.76M

76.82%-2.86M

-162.35%-18.23M

-57.68%1.49M

-141.57%-3.38M

47.41%-4M

-135.50%-12.33M

3,061.41%29.24M

249.65%3.51M

-233.72%-1.4M

-Change in receivables

644.00%372K

72.33%-363K

6.40%-424K

-18.22%395K

228.15%443K

107.61%50K

-216.91%-1.31M

-209.69%-453K

-37.11%483K

136.59%135K

-Change in prepaid assets

206.42%116K

66.67%-156K

-138.81%-943K

-54.35%1.1M

-226.89%-1.46M

-128.61%-109K

68.94%-468K

337.07%2.43M

350.84%2.4M

208.29%1.15M

-Change in payables and accrued expense

437.38%2.86M

68.26%-2.02M

-210.39%-5.76M

-87.63%465K

590.69%1M

-122.54%-848K

-203.33%-6.38M

172.95%5.22M

183.56%3.76M

-117.48%-204K

-Change in other current liabilities

-6.85%-78K

2.70%-72K

-9.63%-444K

-25.00%-155K

-7.58%-142K

1.35%-73K

1.33%-74K

-8.29%-405K

5.34%-124K

-5.60%-132K

-Change in other working capital

83.04%-513K

94.05%-244K

-147.49%-10.66M

89.53%-315K

-36.95%-3.22M

72.57%-3.02M

-110.57%-4.1M

--22.46M

---3.01M

---2.35M

Cash from discontinued investing activities

Operating cash flow

25.84%-14.5M

29.32%-19.3M

-143.06%-85.94M

-1.78%-17.29M

-16.54%-21.78M

3.62%-19.56M

-232.41%-27.3M

47.65%-35.36M

13.34%-16.99M

-16.56%-18.69M

Investing cash flow

Cash flow from continuing investing activities

582.10%9.83M

-29.88%11.69M

167.75%50.77M

75.25%22.23M

175.91%10.43M

110.42%1.44M

127.77%16.68M

-491.12%-74.94M

256.16%12.68M

-186.03%-13.74M

Net PPE purchase and sale

99.88%-1K

18.80%-95K

-92.97%-988K

--0

86.81%-12K

-347.40%-859K

-56.00%-117K

36.71%-512K

-165.52%-154K

-355.00%-91K

Net business purchase and sale

----

0.50%37.19M

----

--37M

----

Net investment purchase and sale

19.63%47.02M

-25.70%-25.4M

169.54%51.76M

73.15%22.23M

176.51%10.44M

388.17%39.3M

66.31%-20.21M

-527.10%-74.43M

259.20%12.84M

-185.35%-13.65M

Cash from discontinued investing activities

Investing cash flow

582.10%9.83M

-29.88%11.69M

167.75%50.77M

75.25%22.23M

175.91%10.43M

110.42%1.44M

127.77%16.68M

-491.12%-74.94M

256.16%12.68M

-186.03%-13.74M

Financing cash flow

Cash flow from continuing financing activities

413.92%24.37M

19.66%24.43M

-3.67%30.65M

-65.65%3.81M

-81.59%1.68M

4,096.46%4.74M

77.77%20.42M

-76.82%31.81M

-81.25%11.08M

-80.55%9.13M

Net common stock issuance

371.51%22.36M

9.58%21.77M

46.88%29.85M

-65.24%3.85M

-84.44%1.4M

--4.74M

7,311.19%19.86M

-84.91%20.32M

-81.29%11.08M

-79.94%8.97M

Proceeds from stock option exercised by employees

--2.01M

380.18%2.67M

-93.08%795K

-4,600.00%-45K

79.25%285K

--0

-95.05%555K

346.91%11.49M

100.87%1K

-92.82%159K

Cash from discontinued financing activities

Financing cash flow

413.92%24.37M

19.66%24.43M

-3.67%30.65M

-65.65%3.81M

-81.59%1.68M

4,096.46%4.74M

77.77%20.42M

-76.82%31.81M

-81.25%11.08M

-80.55%9.13M

Net cash flow

Beginning cash position

6.23%43.1M

-14.59%26.29M

-71.84%30.78M

-26.97%17.53M

-42.53%27.2M

-50.11%40.57M

-71.84%30.78M

109.15%109.28M

-69.18%24M

52.87%47.32M

Current changes in cash

247.24%19.7M

71.83%16.83M

94.25%-4.52M

28.98%8.74M

58.48%-9.67M

60.67%-13.38M

135.04%9.79M

-237.63%-78.48M

-78.42%6.78M

-149.69%-23.3M

Effect of exchange rate changes

-700.00%-8K

-425.00%-13K

213.64%25K

450.00%14K

144.44%8K

---1K

--4K

-540.00%-22K

-180.00%-4K

-140.91%-18K

End cash Position

130.86%62.79M

6.23%43.1M

-14.59%26.29M

-26.97%17.53M

-42.53%27.2M

-50.11%40.57M

-71.84%30.78M

-69.18%24M

Free cash flow

28.96%-14.51M

29.28%-19.39M

-142.40%-86.94M

-0.98%-17.29M

-16.15%-21.82M

0.42%-20.42M

-233.46%-27.42M

47.52%-35.87M

12.92%-17.12M

-16.98%-18.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	25.84%-14.5M	29.32%-19.3M	-143.06%-85.94M	-1.78%-17.29M	-16.54%-21.78M	3.62%-19.56M	-232.41%-27.3M	47.65%-35.36M	13.34%-16.99M	-16.56%-18.69M
Net income from continuing operations	-15.81%-19.8M	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	8.91%-69.46M	-2.87%-21.93M	8.30%-17.57M
Operating gains losses	----	----	---20K	--0	----	----	----	----	----	--0
Depreciation and amortization	4.09%356K	6.29%355K	-1.61%1.4M	16.94%359K	7.58%369K	-10.70%342K	-15.23%334K	-18.60%1.43M	-28.10%307K	-23.27%343K
Other non cash items	73.56%-326K	46.75%-377K	9.60%-3.34M	-171.93%-930K	72.27%-472K	-23.55%-1.23M	-7.93%-708K	-166.81%-3.7M	75.47%-342K	-600.41%-1.7M
Change In working capital	168.88%2.76M	76.82%-2.86M	-162.35%-18.23M	-57.68%1.49M	-141.57%-3.38M	47.41%-4M	-135.50%-12.33M	3,061.41%29.24M	249.65%3.51M	-233.72%-1.4M
-Change in receivables	644.00%372K	72.33%-363K	6.40%-424K	-18.22%395K	228.15%443K	107.61%50K	-216.91%-1.31M	-209.69%-453K	-37.11%483K	136.59%135K
-Change in prepaid assets	206.42%116K	66.67%-156K	-138.81%-943K	-54.35%1.1M	-226.89%-1.46M	-128.61%-109K	68.94%-468K	337.07%2.43M	350.84%2.4M	208.29%1.15M
-Change in payables and accrued expense	437.38%2.86M	68.26%-2.02M	-210.39%-5.76M	-87.63%465K	590.69%1M	-122.54%-848K	-203.33%-6.38M	172.95%5.22M	183.56%3.76M	-117.48%-204K
-Change in other current liabilities	-6.85%-78K	2.70%-72K	-9.63%-444K	-25.00%-155K	-7.58%-142K	1.35%-73K	1.33%-74K	-8.29%-405K	5.34%-124K	-5.60%-132K
-Change in other working capital	83.04%-513K	94.05%-244K	-147.49%-10.66M	89.53%-315K	-36.95%-3.22M	72.57%-3.02M	-110.57%-4.1M	--22.46M	---3.01M	---2.35M
Cash from discontinued investing activities
Operating cash flow	25.84%-14.5M	29.32%-19.3M	-143.06%-85.94M	-1.78%-17.29M	-16.54%-21.78M	3.62%-19.56M	-232.41%-27.3M	47.65%-35.36M	13.34%-16.99M	-16.56%-18.69M
Investing cash flow
Cash flow from continuing investing activities	582.10%9.83M	-29.88%11.69M	167.75%50.77M	75.25%22.23M	175.91%10.43M	110.42%1.44M	127.77%16.68M	-491.12%-74.94M	256.16%12.68M	-186.03%-13.74M
Net PPE purchase and sale	99.88%-1K	18.80%-95K	-92.97%-988K	--0	86.81%-12K	-347.40%-859K	-56.00%-117K	36.71%-512K	-165.52%-154K	-355.00%-91K
Net business purchase and sale	----	0.50%37.19M	----	----	----	----	--37M	----	----	----
Net investment purchase and sale	19.63%47.02M	-25.70%-25.4M	169.54%51.76M	73.15%22.23M	176.51%10.44M	388.17%39.3M	66.31%-20.21M	-527.10%-74.43M	259.20%12.84M	-185.35%-13.65M
Cash from discontinued investing activities
Investing cash flow	582.10%9.83M	-29.88%11.69M	167.75%50.77M	75.25%22.23M	175.91%10.43M	110.42%1.44M	127.77%16.68M	-491.12%-74.94M	256.16%12.68M	-186.03%-13.74M
Financing cash flow
Cash flow from continuing financing activities	413.92%24.37M	19.66%24.43M	-3.67%30.65M	-65.65%3.81M	-81.59%1.68M	4,096.46%4.74M	77.77%20.42M	-76.82%31.81M	-81.25%11.08M	-80.55%9.13M
Net common stock issuance	371.51%22.36M	9.58%21.77M	46.88%29.85M	-65.24%3.85M	-84.44%1.4M	--4.74M	7,311.19%19.86M	-84.91%20.32M	-81.29%11.08M	-79.94%8.97M
Proceeds from stock option exercised by employees	--2.01M	380.18%2.67M	-93.08%795K	-4,600.00%-45K	79.25%285K	--0	-95.05%555K	346.91%11.49M	100.87%1K	-92.82%159K
Cash from discontinued financing activities
Financing cash flow	413.92%24.37M	19.66%24.43M	-3.67%30.65M	-65.65%3.81M	-81.59%1.68M	4,096.46%4.74M	77.77%20.42M	-76.82%31.81M	-81.25%11.08M	-80.55%9.13M
Net cash flow
Beginning cash position	6.23%43.1M	-14.59%26.29M	-71.84%30.78M	-26.97%17.53M	-42.53%27.2M	-50.11%40.57M	-71.84%30.78M	109.15%109.28M	-69.18%24M	52.87%47.32M
Current changes in cash	247.24%19.7M	71.83%16.83M	94.25%-4.52M	28.98%8.74M	58.48%-9.67M	60.67%-13.38M	135.04%9.79M	-237.63%-78.48M	-78.42%6.78M	-149.69%-23.3M
Effect of exchange rate changes	-700.00%-8K	-425.00%-13K	213.64%25K	450.00%14K	144.44%8K	---1K	--4K	-540.00%-22K	-180.00%-4K	-140.91%-18K
End cash Position	130.86%62.79M	6.23%43.1M	-14.59%26.29M	-14.59%26.29M	-26.97%17.53M	-42.53%27.2M	-50.11%40.57M	-71.84%30.78M	-71.84%30.78M	-69.18%24M
Free cash flow	28.96%-14.51M	29.28%-19.39M	-142.40%-86.94M	-0.98%-17.29M	-16.15%-21.82M	0.42%-20.42M	-233.46%-27.42M	47.52%-35.87M	12.92%-17.12M	-16.98%-18.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall